Longevity
Stem Cells for Anti-Ageing & Longevity — What's Real
The decline of the body's repair-cell reserve is real ageing biology. But there's no good evidence that infusing stem cells reverses ageing or extends human lifespan. Here's the honest line between the science and the marketing.
Few corners of the longevity market are noisier than this one. "Stem cell IV therapy" promising to turn back your biological clock; clinics offering to "rejuvenate" you with an infusion; headlines about reversing ageing itself. The strange thing is that underneath all the marketing there is a genuine, serious science — it's just not the science the adverts are selling. This article draws the honest line between the two: what ageing biologists actually mean when they talk about stem cells and ageing, and why the offers built on top of that biology are, for now, running far ahead of the evidence.
The real science: your repair-cell reserve runs down
Throughout your life, small populations of stem cells sit in your tissues as a kind of repair reserve. They divide to replace cells that wear out — refreshing your blood, skin, gut lining, muscle and more. (For a fuller primer on what these cells are and aren't, see what stem cells can actually do.)
As we get older, that reserve does not so much run out as run down. The number of stem cells doesn't simply collapse; rather, the cells that remain become less able to do their job — slower to respond, less able to self-renew, more prone to errors and to drifting in the wrong direction 2. The net result is that tissues repair themselves more slowly and less completely with age. Researchers call this stem-cell exhaustion, and it is one of the recognised hallmarks of ageing — the dozen-or-so biological processes that, together, add up to growing older 1.
This part is real, and it is important. The decline of the body's repair capacity helps explain a great deal of what we experience as ageing: wounds that heal more slowly, an immune system that responds less sharply, tissues that recover less fully after injury. It also sits inside a web of other hallmarks — it is driven along by cellular senescence, by accumulated DNA damage, by a deteriorating tissue environment — rather than acting alone 1. Stem-cell exhaustion is settled enough as biology to appear in the field's defining review. What is not settled is what we can do about it.
It's also worth being precise about why the reserve declines, because the marketing tends to skip it. The story is rarely that the cells have simply vanished and need topping up. Often the opposite is true — in some tissues the number of stem cells stays the same or even rises with age, yet each cell does its job less well 2. The problem is less a shortage of cells than a loss of quality: cells that have accumulated damage, that respond sluggishly to the signals telling them when to divide, and that increasingly produce the wrong kinds of daughter cells. That distinction matters enormously, because if the issue is quality rather than quantity, then pouring more cells in does not obviously fix anything — a point the infusion adverts never pause on.
The leap that isn't supported
Here is where the logic that sells the treatments quietly breaks.
The reasoning sounds airtight: if ageing involves a decline in your stem cells, then surely topping them up — infusing fresh stem cells, usually mesenchymal stem cells (MSCs) harvested from cord tissue, bone marrow or fat — should reverse the decline and rejuvenate you. It is an appealing story. It is also not how the body, or the evidence, actually works.
There is no randomised controlled-trial evidence that stem-cell infusions extend human lifespan or reverse biological age. None. The "reverse your biological age with stem cells" claim is, at the time of writing, a marketing promise rather than a tested finding. Several things stand between the appealing story and reality. Infused MSCs do not generally travel to your tissues and become new, permanent repair cells — most are filtered out by the lungs and cleared within days. To the extent they do anything, it appears to be through temporary signalling: releasing molecules that may damp inflammation for a while, rather than restocking your stem-cell reserve. And "ageing" is not a single deficiency you can correct with a single ingredient; it is the interacting web of hallmarks described above. Adding cells to the bloodstream does not address most of it.
What the human evidence actually shows
It would be unfair to imply nothing has been tried in people — it has, and the honest picture is "early and modest", not "nothing" and certainly not "rejuvenation".
The most relevant work has tested MSC infusions not for "anti-ageing" in the abstract but for frailty — the measurable loss of strength, walking speed and resilience that comes with age. The CRATUS trial is a good example: a small phase II study of 30 older adults (average age about 75) who received a single intravenous infusion of donor mesenchymal stem cells at one of two doses, or a placebo 3. The infusions were safe, with no treatment-related serious adverse events. On function, the results were genuinely mixed: the lower-dose group showed improvements in things like six-minute walking distance and a physical-performance score, while — tellingly — the higher dose did not 3. That is not the clean dose-response you'd want from a real effect, and the authors themselves framed it as a basis for larger trials, not as proof.
Step back and that is the shape of the whole field: a handful of small, short, early-phase human studies, generally showing acceptable safety and occasional modest functional signals, in specific conditions like frailty — alongside a great deal of mouse work and an even greater deal of marketing. What is conspicuously absent is the thing the adverts imply exists: a trial showing that an infusion made people biologically younger or helped them live longer. CRATUS did not measure lifespan or biological age, and neither has anyone else, convincingly. "Promising enough to keep studying" and "ready to sell as rejuvenation" are very different claims, and the gap between them is where the honesty has to live.
What is genuinely worth watching
Healthy scepticism about the clinic offers shouldn't curdle into dismissing the science. Ageing biology is moving, and two threads are worth following — precisely because they are being tested properly rather than sold prematurely.
The first is senolytics: drugs designed to clear out "zombie cells", the senescent cells that accumulate with age and which help wear the stem-cell reserve down in the first place. These have rejuvenated old mice in the lab, and the first small human trials in specific diseases are now under way — a field a leading review describes as genuinely on "the path to the clinic", while stressing that careful trials are still needed to define real benefits and risks 4. The second is exosomes — the tiny signalling parcels that stem cells release, which some researchers think carry much of MSCs' useful effect. They are an active and interesting research area, but in humans they remain firmly preclinical and experimental, which is exactly why we say so plainly in our honest guide to exosome therapy.
The pattern that matters here is the contrast. Senolytics and exosomes are research in progress — being put through trials, with the answers not yet in. "Pay us today to reverse your ageing with a stem-cell drip" is not that. It is a product sold on the strength of research that has not been done.
The honest comparison: speculative infusions vs. the boring stuff
If you want to influence the trajectory of your own ageing, the uncomfortable truth is that the highest-value moves are the ones nobody can sell you in a single visit. Regular exercise — especially anything that builds and keeps muscle — has the strongest, broadest evidence of any longevity intervention we have. Protecting your sleep, never smoking, and keeping your blood pressure, cholesterol and blood sugar in a healthy range do more, on the evidence, than any infusion currently on offer. Our longevity basics piece walks through these in detail. They are unglamorous, they are largely free, and today they comprehensively out-evidence speculative stem-cell rejuvenation.
That is not a counsel of despair — it's the opposite. The best-supported way to keep your repair systems working well for longer is to stop accelerating their decline and to give them the conditions to function. The science of regenerating the reserve itself may one day add to that. It hasn't yet.
How we think about it at Cureon
This is one of the topics people most often arrive asking us to provide — an anti-ageing stem-cell infusion, a biological-age reversal. Our answer is a careful one. We won't offer or endorse stem-cell infusions as a proven way to reverse ageing or extend lifespan, because the human evidence for that simply does not exist yet, and we'd rather lose the sale than make a promise the science can't back. What we do believe in is the honest, physician-led version of healthy ageing: getting the proven foundations genuinely right, measuring what's worth measuring, and watching the regenerative science closely so that if and when a part of it is truly ready for real life, we'll know — and so will you.
Common questions
Can stem cells reverse ageing or make me biologically younger? There is no randomised-trial evidence that stem-cell infusions reverse biological age or extend human lifespan. The decline of your repair-cell reserve (stem-cell exhaustion) is real ageing biology 1, but "topping up" with infused cells has not been shown to undo it. Treat "reverse your biological age" offers as marketing, not medicine.
Is there any good human evidence for anti-ageing stem cells? Only early, small studies — mostly for age-related frailty rather than "ageing" itself. These show acceptable safety and occasional modest, mixed functional signals 3, not rejuvenation or longer life. They are a reason to run bigger trials, not a reason to buy a treatment today.
What happens to stem cells when they're infused into a vein? Most infused mesenchymal stem cells are filtered out by the lungs and cleared within days; they don't generally become permanent new repair cells in your tissues. Any effect appears to come from short-lived signalling, not from restocking your stem-cell reserve.
Are senolytics or exosomes the answer, then? They are the genuinely interesting research — senolytics are in early human trials 4 and exosomes are still in the lab. "Being properly tested" is very different from "proven and for sale". Watch the science; don't pre-buy the conclusion.
So what actually slows ageing right now? The unglamorous foundations: regular exercise (especially building muscle), good sleep, not smoking, and keeping blood pressure, cholesterol and blood sugar in range. On today's evidence these comprehensively beat any speculative infusion.
The honest bottom line
Stem-cell exhaustion — the running-down of your body's repair reserve — is real, recognised ageing biology, and the science of it is serious and worth following 12. The leap from there to "we can infuse stem cells and reverse your ageing" is not supported: no randomised trial has shown that stem-cell infusions extend human lifespan or reverse biological age, and the human evidence that does exist is early, small and modest, in frailty rather than ageing itself 3. The areas genuinely worth watching — senolytics in trials, exosomes in the lab — are research in progress, not products 4. And the proven levers remain the boring ones: move, sleep, don't smoke, look after your heart and metabolism. Watch the science closely. Don't pay for unproven rejuvenation.
Sources
- López-Otín C. et al., Cell (2023) — Hallmarks of aging: An expanding universe
- Schultz M.B. & Sinclair D.A., Development (2016) — When stem cells grow old: phenotypes and mechanisms of stem cell aging
- Tompkins B.A. et al., J Gerontol A Biol Sci Med Sci (2017) — Allogeneic Mesenchymal Stem Cells Ameliorate Aging Frailty: A Phase II Randomized, Double-Blind, Placebo-Controlled Clinical Trial (CRATUS)
- Chaib S., Tchkonia T. & Kirkland J.L., Nature Medicine (2022) — Cellular senescence and senolytics: the path to the clinic
For general information and education only — not medical advice. Read our disclaimer.